ABC | Volume 112, Nº1, Janeiro 2019

Artigo Original Enhos et al Arteriosclerose e PM Arq Bras Cardiol. 2019; 112(1):12-17 1. Bourassa MG, Butnaru A, Lespérance J, Tardif JC. Symptomatic myocardial bridges: Overview of ischemic mechanisms and current diagnostic and treatment strategies. J Am Coll Cardiol. 2003;41(3):351-9. 2. Reyman HC. Disertatio de vasis cordis propriis [dissertation]. Gottingen: Med Diss Univ; 1737. 3. Portmann W, Iwig J. Die intramurale koronarie im angiogramm. Fortschr Rontgenstr 1960;92(2):129-133. 4. BautersC,ChmaitA,TricotO,LamblinN,VanBelleE,LablancheJM.Coronary thrombosis andmyocardial bridging. Circulation. 2002;105(1):130. 5. Rossi L, Dander B, Nidasio GP, Arbustini E, Paris B, Vassanelli C, et al. Myocardialbridgesandischemicheartdisease.EurHeartJ.1980;1(4):239-45. 6. Schwarz ER, Klues HG, VomDahl J, Klein I, Krebs W, Hanrath P. Functional, angiographic and intracoronaryDoppler flow characteristicsin symptomatic patients with myocardial bridging: effect ofshort-term intravenous beta- blocker medication. J Am Coll Cardiol. 1996;27(7):1637-45. 7. Ge J, Erbel R, Rupprecht HJ, Koch L, Kearney P, Gorge G, et al. Comparison of intravascular ultrasound and angiography in the assessment of myocardial bridging. Circulation. 1994;89(4):1725-32. 8. Kneale BJ, Stewart AJ, Coltart DJ. A case of myocardial bridging: evaluation using intracoronary ultrasound, Doppler flow measurement, and quantitative coronary angiography. Heart. 1996;76(4):374-6. 9. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045-51. 10. CanpolatU,ÇetinEH,CetinS,AydinS,AkbogaMK,YaylaC,etal. Association of Monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb Hemost. 2016;22(5):476-82. 11. Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. High-density lipoproteins inhibit cytokine-induced expression of endothelial, cell adhesionmolecules. Arterioscler Thromb Vasc Biol. 1995;15(11):1987-94. 12. Mohlenkamp S, Hort W, Ge J, Erbel R. Update on myocardial bridging. Circulation. 2002;106(20):2616-22. 13. Ishikawa Y, Ishii T, Asuwa N, Masuda S. Absence of atherosclerosis evolution in the coronary arterial segment covered bymyocardial tissue in cholesterol- fed rabbits. Virchows Arch. 1997;430(2):163-71. 14. IshiiT,HosodaY,OsakaT, ImaiT,ShimadaH,TakamiA,etal.Thesignificance of myocardial bridge upon atherosclerosis in the left anterior descending coronary artery. J Pathol. 1986;148(4):279-91. 15. UtukO,BilgeA,BayturanO,TikizH,TavliT,TezcanU.Thrombosisofacoronary artery related to themyocardial bridging. Heart Lung Circ. 2010;19(8):481-2. 16. Kramer JR, Kitazume H, Proudfit WL, Sones FM Jr. Clinical significance of isolated coronary bridges: benign and frequent condition involving the left anterior descending artery. AmHeart J. 1982;103(2):283-8. 17. Masuda T, Ishikawa Y, Akasaka Y, Itoh K, Kiguchi H, Ishii T. The effect of myocardial bridging of the coronary artery on vasoactive agents and atherosclerosis localization. J Pathol. 2001;193(3):408-14. 18. Lee MS, Chen CH. Myocardial Bridging: an up-to-date review. J Invasive Cardiol. 2015;27(11):521-8. 19. Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol. 2006;80(5):1156-64. 20. Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. High-density lipoproteins inhibitcytokine-inducedexpressionofendothelialcelladhesion molecules. Arterioscler Thromb Vasc Biol. 1995;15(11):1987-94. 21. Farb A, Sangiorgi G, Carter AJ, Walley VM, EdwardsWD, Schwartz RS, et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999;99(1):44-52. 22. AkbogaMK,BalciKG,MadenO,ErtemAG,KirbasO,YaylaC,etal.Usefulness ofmonocytetoHDLcholesterolratiotopredicthighSYNTAXscore inpatients with stable coronary artery disease. Biomark Med. 2016;10(4):375-83. 23. Akboga MK, Yayla C, Balci KG, Ozeke O, Maden O, Kisacik H, et al. Relationship between serum albumin level and monocyte-to-high-density lipoprotein cholesterol ratio with saphenous vein graft disease in coronary bypass. Thorac Cardiovasc Surg. 2017;65(4):315-21. 24. Canpolat U, Aytemir K, Yorgun H, Şahiner L, Kaya EB, Çay S, et al. The role of preprocedural monocyte-to high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation. Europace. 2015;17(12):1807-15. 25. Cetin EH, Cetin MS, Canpolat U, Aydin S, Topaloglu S, Aras D, et al. Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Biomark Med. 2015;9(10):967-77. 26. Ucar FM. A potential marker of baremetal stent restenosis: monocyte count - to- HDL cholesterol ratio. BMC Cardiovasc Disord. 2016;16(1):186. 27. Kundi H, Gok M, Kiziltunc E, CetinM, Cicekcioglu H, Cetin ZG, et al. Relation betweenmonocytetohigh-densitylipoproteincholesterolratiowithpresenceand severityof isolatedcoronaryarteryectasia.AmJCardiol.2015;116(11):1685-9. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons Fontes de financiamento Opresente estudo não teve fontes de financiamento externas. Vinculação acadêmica Não há vinculação deste estudo a programas de pós‑graduação. Aprovação ética e consentimento informado Este estudo foi aprovado pelo Comitê de Ética da Bezmialem Vakif Universty sob o número de protocolo 342018. Todos os procedimentos envolvidos nesse estudo estão de acordo com a Declaração de Helsinki de 1975, atualizada em 2013. O consentimento informado foi obtido de todos os participantes incluídos no estudo. 17